TP53 and cancer: Although a slight increase in β-catenin scores was noted in Trp53−/− malignant tumors by immunofluorescence, both Trp53+/+ and Trp53−/− exhibited increased β-catenin expression and cytoplasmic-to-nuclear translocation in highly heterogeneous tumor populations.